12 HA'ILAN STREET, NORTHERN INDUSTRIAL, OR AKIVA, L3
Interim Condensed Financial Statements as of and for the Six Months Ended June 30, 2026 (Unaudited)
Receives Japanese Patent Allowance, Strengthening Its Global GelrinC Intellectual Property Portfolio with New Proprietary Manufacturing Technology
Receives European Regulatory Approval for New GelrinC Manufacturing Process, Increasing Production Yield by 400% Ahead of European Commercial Launch
Approves Proposals at Adjourned Annual General Meeting of Shareholders
Annual General Meeting Adjourned Due to Lack of Quorum
Announces Pricing of a $6.5 Million Private Placement
Files Request for Withdrawal of Registration Statement
To Commence European Surgeon Training for GelrinC in Knee Cartilage Repair as Commercial Launch Preparations Accelerate
Amended Annual and Transition Report of Foreign Private Issuers
Annual and Transition Report of Foreign Private Issuers
Effectiveness Notice
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities of Certain Foreign Private Issuers
Notice of Exempt Offering of Securities
RW
Amended Registration Statement for Securities of Certain Foreign Private Issuers
No filings found
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Post-Effective Amendment to Registration Statement
Free Writing Prospectus